Lexology August 22, 2024
Questel

Navigating the complex regulatory compliance landscape in the life sciences sector is a formidable challenge, especially when dealing with medical devices and pharmaceutical translations. The European Union Medical Device Regulation (EUMDR) and In Vitro Diagnostic Regulation (IVDR) have introduced stringent requirements, making it more crucial than ever for companies to avoid common pitfalls. As the Director of Life Sciences Business Development, I have observed how these regulations impact our industry and the vital role of high-quality translation in achieving compliance.

Here, I’ll share ten tips to help you overcome these challenges and ensure your translations meet regulatory standards.

1. Understand the Regulatory Landscape

Before embarking on any translation project, it’s essential to understand the regulatory requirements of the target market...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma / Biotech, Regulations
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
US health dept providing Moderna $590 mn to speed mRNA bird flu vaccine
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Pharma Pulse 1/17/25: Compounding Pharmacies and Meeting Patient Needs, Survey Shows Gaps in Consumer Awareness & more

Share This Article